Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjun Wu

Showing results (431-440 of 455) with videos related to

Pageof 46
Sort By:
Frontiers in Oncology|January 5, 2026
Prognostic factors of patients with intravascular large B cell lymphoma: a multicenter study in ChinaYan Guo, Yi Zhong, Lixia Zhu, et al.
Drug Design, Development and Therapy|November 12, 2025
Integrating Clinical Multi-Omics, Machine Learning, and Molecular Docking Strategies to Reveal the Mechanism of Yiqi Huoxue Prescription in the Treatment of Ischemic Heart FailureJingjing Wei, Lijie Qiao, Peng Yu, et al.
Annals of Hematology|October 24, 2025
Developmental stage modulates the prognostic impact of RAS pathway mutations in AML patients undergoing Allo-HSCTXiaolin Yuan, Yibo Wu, Yanan Wang, et al.
Journal of Colloid and Interface Science|January 24, 2025
Unraveling the role of Ta in the phase transition of Pb(Ta<sub>1+x</sub>Se<sub>2</sub>)<sub>2</sub> using temperature-dependent Raman spectroscopyYu Ma, Chi Sin Tang, Xiaohui Yang, et al.
Annals of Hematology|January 22, 2025
Adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation and tyrosine kinase inhibitors: development and validation of a clinical prediction model based on cytogenetics, IKZF1 deletions and minimal residual diseaseJing Zheng, Yuping Zhou, Yanmin Zhao, et al.
Nature Communications|September 9, 2022
CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignanciesYongxian Hu, Jingjing Li, Fang Ni, et al.
Bioactive Materials|March 21, 2023
Dual-bionic regenerative microenvironment for peripheral nerve repairYanjun Guan, Zhiqi Ren, Boyao Yang, et al.
Blood Advances|February 11, 2021
Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2Wenjun Wu, Weige Wang, Carrie A Franzen, et al.
Blood Cancer Journal|February 19, 2021
Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradicationPin Lu, Shengchun Wang, Carrie A Franzen, et al.
Nature Communications|March 28, 2024
Author Correction: CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignanciesYongxian Hu, Jingjing Li, Fang Ni, et al.
Pageof 46

Showing results (431-440 of 455) with videos related to

Sort By:
Pageof 46
Frontiers in Oncology|January 5, 2026
Prognostic factors of patients with intravascular large B cell lymphoma: a multicenter study in ChinaYan Guo, Yi Zhong, Lixia Zhu, et al.
Drug Design, Development and Therapy|November 12, 2025
Integrating Clinical Multi-Omics, Machine Learning, and Molecular Docking Strategies to Reveal the Mechanism of Yiqi Huoxue Prescription in the Treatment of Ischemic Heart FailureJingjing Wei, Lijie Qiao, Peng Yu, et al.
Annals of Hematology|October 24, 2025
Developmental stage modulates the prognostic impact of RAS pathway mutations in AML patients undergoing Allo-HSCTXiaolin Yuan, Yibo Wu, Yanan Wang, et al.
Journal of Colloid and Interface Science|January 24, 2025
Unraveling the role of Ta in the phase transition of Pb(Ta<sub>1+x</sub>Se<sub>2</sub>)<sub>2</sub> using temperature-dependent Raman spectroscopyYu Ma, Chi Sin Tang, Xiaohui Yang, et al.
Annals of Hematology|January 22, 2025
Adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation and tyrosine kinase inhibitors: development and validation of a clinical prediction model based on cytogenetics, IKZF1 deletions and minimal residual diseaseJing Zheng, Yuping Zhou, Yanmin Zhao, et al.
Nature Communications|September 9, 2022
CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignanciesYongxian Hu, Jingjing Li, Fang Ni, et al.
Bioactive Materials|March 21, 2023
Dual-bionic regenerative microenvironment for peripheral nerve repairYanjun Guan, Zhiqi Ren, Boyao Yang, et al.
Blood Advances|February 11, 2021
Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2Wenjun Wu, Weige Wang, Carrie A Franzen, et al.
Blood Cancer Journal|February 19, 2021
Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradicationPin Lu, Shengchun Wang, Carrie A Franzen, et al.
Nature Communications|March 28, 2024
Author Correction: CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignanciesYongxian Hu, Jingjing Li, Fang Ni, et al.
Pageof 46